Theravance News

Xtremepicks.com Alerts include SEI , Inergy, L.P. , Virage Logic Corporation and Theravance, Inc.

South San Francisco-based Theravance Inc. declined the most in a month in New York trading after failing to gain U.S. approval for an expanded use of its antibiotic treatment for MRSA hospital infections.

Theravance, Inc. announced today that it received a Complete Response letter from the U.S. Food and Drug Administration related to the telavancin New Drug Application for the treatment of nosocomial pneumonia .

Shares of the following companies may have unusual moves in U.S. trading on Nov.

South San Francisco-based Theravance Inc. and Astellas Pharma Inc. failed to win approval from U.S. regulators to expand the use of their antibiotic, telavancin, to treat pneumonia acquired by hospitalized patients.

Theravance Inc. said Friday the Food and Drug Administration delayed a decision on whether to approve its infection drug Vitabiv as a treatment for hospital-acquired pneumonia.

Main Category: Dermatology Also Included In: Infectious Diseases / Bacteria / Viruses Article Date: 06 Nov 2009 Theravance, Inc.

Astellas and Theravance, Inc. announced today that Astellas Pharma Europe B.V. submitted a Marketing Authorization Application to the European Medicines Agency for telavancin, a bactericidal, once-daily injectable lipoglycopeptide antibiotic, for the treatment of nosocomial pneumonia , including ventilator-associated pneumonia, and complicated skin ...

Theravance, Inc. October 27, 2009, 2009 5:00 pm ET Executives Mike Aguiar - SVP and CFO Rick Winningham - CEO Analysts Tom Russo - Baird Michael Aberman - Credit Suisse Brian Skorney - ThinkEquity Ian Sanderson - Cowen & Company Presentation Operator I would like to welcome everyone to the Theravance Conference Call to review results for the ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

GlaxoSmithKline and Theravance, Inc. today announced that the first patient has commenced treatment as part of the Phase III programme being undertaken to develop a next-generation combination treatment for patients with chronic obstructive pulmonary disorder , a leading cause of chronic illness and death.

BUYINS.NET, www.buyins.net, has reviewed the NYSE, NASDAQ, BX, CHX and NSX Daily Short Volume Report for Thursday, October 15th, 2009 and come to the following statistical conclusions.

BUYINS.NET, www.buyins.net, has reviewed the NASDAQ Daily Short Volume Report for Thursday, September 17th, 2009 and come to the following statistical conclusions.

Amid the doom and gloom that seemed to pervade the BioPharm America conference this week , some interesting glimmers of light appeared on the local biotech front.

Theravance Inc. on Friday announced that FDA has approved the marketing of telavancin for injection, or Vibativ, for the treatment of complicated skin and skin-structure infections in adults.

Theravance Inc. and Astellas Pharma Inc. said they received U.S. approval to market a new antibiotic for hard-to-treat skin infections such as methicillin-resistant Staphylococcus aureus, or MRSA , which kills almost 19,000 Americans a year.

Theravance and Astellas Announce FDA Approval of VIBATIV for the Treatment of Complicated Skin and Skin Structure Infections © Marketwire 2009 2009-09-12 05:30:05 - SOUTH SAN FRANCISCO, CA and DEERFIELD, IL -- -- 09/11/09 -- Theravance, Inc.

News And FDA Updates For Theravance , Auxilium , Infinity Pharma , Momenta BioMedReports.com , the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA ...

News And FDA Updates For Amgen , Covidien , MEDNAX , And Theravance BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA ...

This report is an update to a previous version and is updated to 24th April 2009.